Table 3 Echo and ECG assessment by critical and non-critical cases.
Items | Non-critical group | Critical group | p-value |
|---|---|---|---|
Normal ECG | 111 (77.0%) | 2 (3.5%) | < 0.001 |
Abnormal ECG | 33 (22.9%) | 55 (96.5%) | |
Tachycardia | 16 (27.1%) | 43 (72.8%) | < 0.001 |
Atrial fibrillation | 4 (19%) | 17 (80.09%) | < 0.001 |
Anteroseptal ST depression | 12 (36.6%) | 20 (36.6%) | < 0.001 |
Anteroseptal T wave inversion | 9 (27.2%) | 12 (21.8%) | |
Anteroseptal ST elevation | 2 (6.06%) | 7 (12.7%) | |
Q wave inferior leads | 3 (9.09%) | 0 (0.0%) | |
RBBB | 7 (21.2%) | 16 (29.0%) | |
Normal echo | 126 (69.6%) | 21 (11.6%) | < 0.001 |
Abnormal echo | 1 (0.5%) | 33 (18.23%) | |
LV dysfunction | 1 (0.5%) | 4 (2.2%) | < 0.001 |
RV dilatation, RV dysfunction | 0 (0.0%) | 25 (13.8%) | |
Biventricular dysfunction | 0 (0.0%) | 4 (2.2%) | |
Ejection fraction | |||
≥ 60% | 112 (6.8%) | 18 (9.9%) | < 0.001 |
40–59% | 15 (8.2%) | 32 (17.6%) | |
< 40% | 1 (0.5%) | 3 (1.65%) | |
Discharge patients | 144 (77.0%) | 43 (22.9%) | < 0.001 |
Death | 0 (0.0%) | 14 (6.96%) | |
